The interaction between interleukin-6 (IL-6) and IL-6 receptor the contact region and to interact with each other. We stud-(IL-6R) is the initial and most specific step in the IL-6 signalied the capacity of these mutants to form an IL-6/IL-6R coming pathway. Understanding its mechanism at the amino plex and their ability to transduce the signal. This combined acid level is the basis for developing small IL-6-inhibiting approach has led to the identification of certain residue-clusmolecules. We studied the human IL-6 (hIL-6)/hIL-6R binding ters in the binding interface and to a rational explanation of interface by a combination of molecular modelling and sitetheir specific interactions, suggesting therein a likely mechadirected mutagenesis. Our model suggests that the center nism of complex formation. The results confirm the preof the interface between the two molecules consists of hydictive model and strongly support our hypothesis. Compardrophobic contacts predicted to account for most of the ison with other cytokines and their a-subunit receptors binding-free energy. These contacts can be regarded as a suggests that the structural location of certain binding sites hydrophobic core shielded by hydrophilic residues that are are conserved. also needed for recognition. Following this hypothesis, we ᭧ 1997 by The American Society of Hematology. altered in hIL-6 and hIL-6R residues predicted to reside in postmenopausal osteoporosis, chronic autoimmune diseases,
1
activities through the interaction with specific receptors exAttempts to specifically limit the overproduction of IL-6 pressed on the surface of target cells. IL-6 binds first to or its consequences can be made either at its site of produca low-affinity a-subunit, a 80-kD glycoprotein called tion or at its target. The IL-6 overproduction can be specifireceptor (IL-6R) or gp80. This IL-6/IL-6R complex recruits cally decreased by inhibition of its mRNA transcription or the signal-transducing b-subunit, a 130-kD glycoprotein translation by antisense oligonucleotides or ribozyme action. called gp130. The association of gp130 with IL-6 and ILThese methods were shown to be effective on cells in culture 6R leads to the formation of the high-affinity IL-6R complex, but are not yet developed enough for use in vivo. 13, 14 Two to the covalent linkage of two gp130 subunits, and to signal approaches have been used to inhibit the action of IL-6. In transduction. gp130 does not bind IL-6 or IL-6R on their the first approach, mutational analyses of IL-6 and sIL-6R own. It associates only with the preformed IL-6/IL-6R comhave yielded several antagonists that bind to the correspondplex.
2,3 Recent studies have suggested that the high-affinity ing wild-type molecules and form an IL-6/IL-6R complex IL-6R complex is a hexamer formed by two distinct IL-6, but fail to transduce the signal. These mutants were shown IL-6R, and gp130 molecules. 4, 5 to inhibit IL-6 activity in cell cultures but have not yet been Furthermore, the cytoplasmic and transmembrane dotested in the organism, mostly because the amounts needed mains of IL-6R are not needed for the transduction of the are too high. [15] [16] [17] [18] [19] In a second approach, murine monoclonal signal. IL-6R is often secreted in a soluble form (sIL-6R) antibodies (MoAbs) directed against human IL-6 (hIL-6) or that binds IL-6 and is biologically active as an agonist, renhIL-6R that block either the binding between hIL-6 and hILdering cells expressing gp130 but not IL-6R responsive to 6R or between the hIL-6/hIL-6R complex and gp130 were IL-6. 6, 7 used. Clinical trials have shown that such MoAbs were suc-IL-6 is predicted to fold as a four a-helix bundle protein cessful in decreasing the IL-6-related symptoms in patients belonging to the hematopoietin cytokine family. Like growth hormone (GH), it was classified to be one of the long chain members of the family. 8, 9 The two IL-6 receptor subunits, IL- Kalai et al. 28 For graphic representation of the structures, the proof certain diseases. [20] [21] [22] [23] Although the use of such MoAbs grams GRASP 31 and RIBBONS 2.0 32 running on an Indigo2 SGI seems most promising at the moment, the amount of MoAbs were used (Silicon Graphics Inc, Mountain View, CA).
needed is very high, their mode of administration is not very convenient, and human antimouse Ig antibody responses Generation of shIL-6R and hIL-6 Mutant cDNAs were encountered. 23 Therefore, the search for other means Site-directed mutagenesis was performed using an oligonucleoto inhibit hIL-6 activity should continue.
tide-directed in vitro mutagenesis system (Amersham, Amersham,
Understanding the mechanism of interaction between hIL-UK) and synthetic oligonucleotides as primers, as described be-6 and hIL-6R by identifying the amino acids involved may fore. [28] [29] [30] 33, 34 The single-stranded DNA (ssDNA) of M13mp19-ILlead to the development of small and simple IL-6-inhibiting 6R was used as template for the hIL-6R mutations. The ssDNA of molecules. Although some x-ray crystallography and nuclear pBS-IL-6 0 was used as template for mutation hIL-6, with the excepmagnetic resonance (NMR) structural information is availtion of mutant F74E,F78E, for which the ssDNA of mutants F74E
able for a few members of the cytokine family, 9,24 only two and F78E was used. The sequence of the primers used for mutagene-
x-ray structures of a cytokine/receptor complex were resis of hIL-6R and hIL-6 are available on request.
ported so far. These are the structures of hGH bound to an
The resulting hIL-6R mutant cDNAs were amplified by polymerase chain reaction (PCR) according to standard protocols 35 binding energy and hydrophilic residues that could be responsible for the recognition and the specificity of the interProduction of WT and Mutant shIL-6 R and hIL-6 action. [27] [28] [29] [30] Following this hypothesis and the predictions of Proteins our model, we analyzed in detail a series of hIL-6 and hIL-
The EcoRI-linearized pSP64T-sgp80R and pBS-IL-6 0 plasmids 6R mutants; certain members of this series permitted us to and their mutant derivatives were transcribed in vitro and the correidentify binding sites that had not been discovered earlier.
sponding mRNAs were translated following their micro-injection
Our results shed light on how the IL-6/IL-6R complex is into Xenopus laevis oocytes, as described earlier. 28, 30, 36 assembled in detail. They show that the predictions of the model were most probably correct and strongly support our Determination of hIL-6 and shIL-6R Protein hypothesis. Comparison with other cytokines and their correConcentrations sponding a-subunit receptors suggests that the topography hIL-6 and shIL-6R protein concentrations were determined using of the related binding epitopes is partially conserved.
the following enzyme-linked type antibody sandwich immunometric assays.
For hIL-6, we used microtiter plates coated with 100 mL/well of MATERIALS AND METHODS 5 mg/mL of anti-hIL-6 MoAb AH-65 (Immunotech SA, Marseilles,
Molecular Modelling of the hIL-6/hIL-6R Complex
France) to capture and a biotinylated anti-hIL-6 MoAb B-E4 (B-E4-Bio) to detect bound hIL-6 molecules. B-E4 (kindly provided by The methods used for the homology-based modelling of hIL-6 and of hIL-6R using the x-ray structures of granulocyte colonyDr J. Wijdenes, Diaclone, Besançon, France) was biotinylated using a protein biotinylation kit according to manufacturer's instructions stimulating factor (G-CSF) and hGHR, respectively, as templates were described previously in Ehlers et al, 17 Grötzinger et al, 27 and (Boehringer Mannheim, Mannheim, Germany). Bound biotinylated was measured with a liquid-scintillation b-counter.
In Vitro hIL-6 and hIL-6R Binding Assay Analysis of the Conformational Integrity of hIL-6 and
The potential of mutant and WT hIL-6 and shIL-6R to form an
shIL-6R Variants
hIL-6/hIL-6R complex in solution with the corresponding WT partThe conformational integrity of the hIL-6 variants was assessed ners was tested by an enzyme-ligand immunoassay using microtiter using the enzyme-linked-type antibody sandwich immunometric plates coated with anti-hIL-6 MoAb AH-65 37 (Immunotech) to capassays we described above by requantification of equal amounts of ture and with anti-hIL-6R MoAb M-91-AP (Immunotech) to detect each variant at a subsaturation concentration using a larger group formed hIL-6/shIL-6R complexes, as described. 28, 38 of MoAbs, including at least some that are conformation-dependent.
For hIL-6, we used MoAbs AH-64, AH-65 (Immunotech), 8, 16 Murine 7TD1 Hybridoma Cell Growth Assay all of the MoAbs that recognized the given variant well. subsequently incubated in triplicate with a serial dilution of WT or mutant hIL-6 for 3 days at 37ЊC in 5% CO 2 , humidified. Cell RESULTS proliferation was measured after incubation using the XTT cell pro-
Architecture of the hIL-6/hIL-6R Binding Interface
liferation kit II (Boehringer Mannheim) according to the manufacturer's instructions.
We have recently described 27 ,28 the computer-assisted modelling of the structure of the hIL-6/hIL-6R complex usHuman A375 Melanoma Cell Growth Arrest Assay ing the x-ray structures of hGCSF 43 and of hGH bound to
The growth arrest of the IL-6-sensitive A375 cells was performed the hGHR 25 as templates. We used this model here ( Fig 1A) as previously described. 30 Briefly, cells were seeded at a density of to identify amino acids participating in the contact region For personal use only. on April 15, 2017 . by guest www.bloodjournal.org From A-helix and Arg168, Arg179, and Arg182 from the D-helix F78E, and the double mutant F74E,F78E, thus replacing the aromatic and hydrophobic phenylalanines by the hydroof hIL-6 (Fig 1C and D and Fig 2B and C) and Arg250, Arg252, Glu254, Asp272, Glu296, Glu297, and Glu302 of philic, charged glutamic acids. As seen in Figs 3 and 4, these replacements have nearly abolished the binding to shIL-6R. hIL-6R (Fig 1B and D and Fig 2B and C) .
Unlike wild-type hIL-6, corresponding mutants did not sigImportance of Type of Residue, Size, and Charge for nificantly decrease the growth of the human A375 melanoma Interactions at the hIL-6/hIL-6R Binding Interface cells (Fig 4A) , and they did not stimulate the growth of the human XG-1 myeloma cells (Figs 3 and 4B ). The effect of According to the structural model, the interactions demutagenesis was more pronounced in the case of the double scribed above should be crucial for maintaining the binding mutant F74E,F78E that did not bind to hIL-6R and failed to capacities of hIL-6 and its receptor.
show any XG-1 cell growth stimulation, even at a concentraFollowing this assumption, we selected amino acids from tion of 25 ng/mL (Fig 3) . These results support the prediction each of the two proteins and modified their type or size by that both residues participate in the binding to hIL-6R. site-directed mutagenesis. Hydrophobic residues were reAs seen in Fig 2A, Phe248 and Tyr249 are at the center placed by hydrophilic amino acids and vice versa. The of the predicted binding site, whereas Tyr188 is more periphcharge of certain hydrophilic amino acids was reversed from eral and thus should be a minor participant in the binding positive to negative and vice versa. Large residues were process. These predictions are fully supported by the results replaced by smaller ones and small residues were replaced shown in Fig 5. Replacement of Phe248 by the polar and by larger ones.
uncharged serine (mutant F248S) and of Tyr249 by the hyMutant proteins were produced and the hIL-6R binding drophilic arginine (mutant Y249R) decreased the hIL-6 bindand signal-transduction capacities of the resulting hIL-6 muing capacity of the mutants to an almost undetectable level tants and the hIL-6 binding capacity of the resulting shIL- (Fig 5) . The observation that similar results were obtained 6R mutants were tested. when these residues were replaced by the hydrophobic valine Aromatic and hydrophobic interactions between hIL-6 (F248V and Y249V) suggests that the aromatic nature of and hIL-6R. We showed previously that Tyr188, Phe248, these residues is more important than their hydrophobicity and Tyr249 of hIL-6R are necessary for hIL-6 binding and for interaction with hIL-6 (Fig 5) . Replacement of Tyr188 signal transduction. 28 It was recently shown that two synby the hydrophilic arginine (Y188R) resulted in a stronger thetic peptides with amino acid sequences corresponding to effect on the IL-6 binding potential of the corresponding residues 237-250 and 240-253 of hIL-6R, respectively, can mutant than that of its replacement by the hydrophobic valine bind hIL-6. 44 As seen in Fig 2A, Tyr188 , Phe248, and Tyr249 (Y188V) or the aromatic and hydrophobic phenylalanine of IL-6R are predicted to interact with two phenylalanine (Y188F; Fig 5) . This finding suggests that the interaction at residues, 74 and 78, located at the end of the AB loop of this site is hydrophobic, as predicted. The observation that hIL-6. Previous studies suggested that an hIL-6R binding mutant Y188R still kept about 35% of the WT IL-6 binding site could be found between residues 77 and 95 17 or between residues 63 and 113 of hIL-6. 45 We produced mutants F74E, capacity supports the suggestion that Tyr188 is a less-im- portant participant in this binding site. As expected, the double mutant Y188R,Y249R did not bind hIL-6 at all. These results show that these three residues are crucial for IL-6 binding and stress the importance of their aromatic nature. Furthermore, our model suggests that other hydrophobic amino acids may also contribute to this interaction zone. Leu127 of hIL-6R may increase the hydrophobic background of the interaction between Tyr188, Tyr249 (hIL-6R), and Phe74 (hIL-6), whereas Ile189 and Val190 of hIL-6R may interact with Met67 of hIL-6. The amount of experimental support to this prediction is still limited. No mutants of Met67 of hIL-6 were studied so far. Removal of the side chain of Val190 (mutants V190G and S186l,Val190G) decreased the binding to hIL-6 significantly (Fig 5) . An earlier study showed that a Val190G hIL-6R mutant did not bind gp130 and was biologically inactive. 46 These results may indicate that Val190 is directly involved in the binding of hIL-6; however, the removal of the side chain might have disrupted the local structure of the EF-loop of hIL-6R, as we suggested previously.
28 The hIL-6 binding capacity of mutant F187I was twice as high as that of WT shIL-6R. The addition of the substitution of Ile189 to the larger tyrosine (mutant F187I,I189Y) brought it back to the WT level ( Fig  5) .
As described above, our model predicted a second hydrophobic interaction zone between hIL-6 and hIL-6R. This hydrophobic cluster includes residues Phe298 of hIL-6R (Fig  1B and D) and residues Ile29, Ile32, Leu33, Ile36, Leu174, and Leu178 of hIL-6 (Fig 1C and D) . Several results indicate the existence of this second hydrophobic interaction zone. In an earlier hIL-6 mutagenesis study, we reported that re- Furthermore, Yawata et al 46 Glu297 by alanine coupled with the substitution of Phe298 was reversed from positive to negative by replacing Arg179 and Arg182 by glutamic acids (R179E and R179E,R182E) by isoleucine resulted in the complete loss of hIL-6 binding.
Hydrophilic residues and salt bridge formation between was somewhat stronger (Figs 3 and 4) . Changing Arg to Glu resulted in the shortening of the side chain and thus in hIL-6 and hIL-6R. Our model predicted that salt bridges form between the positively charged Arg179 and Arg182 of unshielding of the hydrophobic core. It may have also resulted in the repulsion of the two negative charges contribhIL-6 and the negatively charged Glu296 and Glu297 of hIL-6R (Figs 1D and 2B) . Thus, in addition to the possible uted now by both IL-6 and its receptor. Replacements of glutamic acids 296 and 297 of hIL-6R hydrophobic interactions involving the long side chains (methylene groups) of these arginines, their positively by arginine (E296R, E297R, and E296R,E297R) resulted in complete loss of binding to hIL-6 (Fig 5) . These results show charged head groups are fixed in salt bridges keeping the side chains in such a position that they can shield the hythat these four amino acids are crucial for the recognition and binding of IL-6 and IL-6R. The effects observed for the drophobic core of the interaction from the access of water. Replacing Arg179 by the aromatic hydrophobic tryptophan charge reversal experiments support the suggestion that these amino acids are involved in the formation of salt bridges (R179W) resulted in the loss of binding to hIL-6R and biologic activity (Fig 3) . The effect obtained when the charge between the two molecules.
For personal use only. on April 15, 2017. by guest www.bloodjournal.org From It was recently shown that minibody b-polypeptides caris described by us in another report. 27 We analyzed here the effects of substitutions of several amino acids in hIL-6 rying an amino acid sequence similar to that found between residues Arg293 and Glu297 of hIL-6R in one of their bpredicted to be important for the interaction with hIL-6R, on the capacity of the mutants to stimulate the growth of loops can bind IL-6 and competitively inhibit the formation of an IL-6/IL-6R complex. 47 Evidence for the involvement 7TD1 murine hybridoma cells. Differences were observed mainly for mutants F74E of Arg250 and Arg252 of hIL-6R in hIL-6 binding was obtained when this inhibitor was improved by the addition and F78E. The homologues of phenylalanines 74 and 78 in hIL-6 are the polar uncharged, aromatic tyrosines 73 of an amino acid sequence similar to that found between residues Arg250 and Phe253 of hIL-6R in another b-loop. 48 and 77 in mIL-6. In addition, Tyr188 and Phe248 in the hIL-6R correspond to His186 and Tyr245 in the mIL-6R. In addition, synthetic peptides with amino acid sequences corresponding to Tyr249 to Arg258 in hIL-6R were shown This finding suggests that this contact region in the mIL-6/mIL-6R binding interface is dominated by aromatic into bind hIL-6 44 or to decrease its activity. 49 Another pair of amino acids predicted to form a salt bridge teractions. It is possible that the negatively charged glutamic acid between hIL-6 and hIL-6R is shown in Fig 2C. Arg30 of hIL-6 is predicted to interact with Glu254 of hIL-6R. The that replaced Phe74 in mutant F74E is able to interact with the positively charged His186 of mIL-6R. The retriple mutant R30T,Y31H,I32V, in which the hydrophilic Arg30 is replaced by the polar uncharged threonine, has lost placement of Phe78 by glutamic acid in mutant F78E and in the double mutant F74E,F78E should be more difficult most of its hIL-6 binding capacity (Fig 3) . In this mutant, the region between amino acids 30 and 32 in hIL-6 was to accommodate. Indeed, mutant F74E was nearly as active as the WT in exchanged for the analogous region of mIL-6. When compared with the WT, this mutant was only three times less the 7TD1 growth stimulation assay, whereas mutant F78E active in the murine 7TD1 cell growth assay. In contrast, its was about six times less active. The double mutant D 50 value obtained for the human XG-1 cells was at least F74E,F78E was about 46 times less active (Figs 3 and 4). 10 times larger than that of the WT. The decrease in binding Substitution of Arg168 seems to affect the interaction with to hIL-6R can be attributed mainly to the substitution of hIL-6R more than the interaction with mIL-6R. Mutant Arg30 because (1) previous studies showed that Tyr31 is R168M could hardly stimulate the growth of human XG-1 involved in gp130 binding and not in IL-6R binding 18, 50 ; (2) cells and was about seven times less active in the murine mutant I32M showed a slight increase in hIL-6R binding 7TD1 cell growth assay as compared with the WT control and was twice as active on the human XG-1 cells as the (Fig 3) . Probable equivalents for Arg168 of hIL-6 and WT control, without showing any significant change in the Glu302 of hIL-6R in the murine proteines are Lys168 and activity on the murine cells; (3) deletion of residues 29 and Asp296, respectively. Arginines 179 and 182 of hIL-6 and 30 in hIL-6 resulted in a significant decrease in activity 34, 51 ; glutamic acids 296 and 297 of hIL-6R are conserved residues and (4) another extensive mutagenesis study of hIL-6R sugin the corresponding murine molecules (Arg179, Arg182, gested that Glu254 is involved in IL-6 binding. 46 Glu293, and Glu294, respectively). These amino acids are The residue predicted by our hIL-6/hIL-6R model to intercrucial for the function in the human and the murine systems act directly with Arg168 of hIL-6 is Glu302 of hIL-6R (Fig (Figs 3 and 4) . These results are supported by previous re-2D). Substitution of Arg168 by the hydrophobic methionine ports. 29, 45, 47 (mutant R168M) resulted in an almost complete loss of binding to hIL-6R and growth stimulation of human XG-1 cells.
Analysis of the Conformational Integrity of the hIL-6 and
In an earlier report, we showed that this mutant bound very shIL-6R Mutants weakly to human A375 melanoma cells and had only a mild effect on their growth. 30 Mutation of Glu302 of hIL-6R was To determine if the decrease in activity observed for some reported earlier to result in complete loss of binding to hILof the hIL-6 and shIL-6R mutants was due to a modification 6. 46 in the region of contact between the two molecules or due Gln175 and Met184 from hIL-6 are examples of amino to a more drastic change in their tertiary structure, conformaacids located at the hIL-6/hIL-6R binding interface that were tional analysis was performed for all of these proteins. not predicted by our model to be directly involved in the Among the tools used as sensitive probes for structural alterbinding process. The substitutions of these residues by an nations in mutant proteins are conformation-dependent hydrophobic or hydrophilic amino acid (mutants Q175L and MoAbs.
28-30
M184K, respectively) had a relatively small effect on their Recognition of the hIL-6 mutants by conformation-depenhIL-6R binding and signal-transducing capacities (Fig 3) . dent anti-hIL-6 MoAbs. A previous study has shown by immunoprecipitation of S 35 -labeled hIL-6 in the presence or Differences Between the hIL-6/hIL-6R and hIL-6/mIL-6R absence of 0.1% SDS that anti-hIL-6 MoAb 12 recognized Binding Interfaces preferentialy native hIL-6, whereas anti-hIL-6 MoAb 7 reacted better with the denatured form of the antigen. To show The murine IL-6R (mIL-6R) binds and transduces the that anti-hIL-6 MoAbs B-E4, AH-65, and 16 are conformasignal of both human and mIL-6, whereas the hIL-6R is tion-dependent, we compared their potential to recognize the species-specific. 36, 52 The homology between hIL-6 and mILnative and denatured hIL-6 by dot blot analysis with that of 6 and between hIL-6R and mIL-6R is limited. An explanation of the species specificity of the IL-6/IL-6R interaction MoAbs 7 and 12 ( Fig 6A) . with the denatured hIL-6 was MoAb 7; the other four reacted cipitation of S 35 -labeled shIL-6R in the presence or absence of 0.1% SDS or after the boiling of the antigen for 10 minutes better with the native protein.
The only MoAb to react well
Analysis of the recognition of all of the hIL-6 mutants ( Fig 7B) . Both MoAbs failed to recognize the denatured shIL-6R, whereas Pc-Rb recognized it to a certain degree studied here by sandwich enzyme-linked immunosorbent assay (ELISA) using either AH-65 or MoAb 16 as phase and even well, depending on the treatment (Fig 7B) . Analysis of the recognition of our shIL-6R mutants by a and biotinylated B-E4 as tracer has shown that all of these hIL-6 variants were recognized as well as the WT hIL-6 by sandwich ELISA using MoAbs 17.6, 22.1,M-182, 34.4 (Fig  7C) , 32.3, and 38.8 (not shown) as phase and the alkaline the three conformation-dependent anti-hIL-6 MoAbs ( Fig  6B) . This finding suggests that the these amino acid substituphosphatase-conjugated MoAb M-91 as tracer has shown that the conformational and structural integrity of most of tions did not drastically affect the general tritiary structure of the proteins.
these mutants was conserved. The only exceptions were mutants of Ser186 and Val190, Recognition of the shIL-6R mutants by conformation-dependent anti-hIL-6R MoAbs. To evaluate the conformawhich were recognized less by MoAb 34.4 (Fig 7C) and MoAbs 32.3 and 38.8, which gave very similar results (not tional integrity of our shIL-6R mutant, we followed a similar approach. The conformation dependence of eight anti-hILshown). Mutant V190G was recognized better than the WT shIL-6R by MoAb M-182 (Fig 7C) . This MoAb recognized 6R Abs was assessed by their potential to recognize the native and denatured hIL-6 by dot blot analysis (Fig 7A) .
the denatured shIL-6R better than the native antigen in the dot blot analysis (Fig 7A) . These results support our previous The results obtained have shown that MoAbs 17.6, 22.1, 32.3, 34.4, 38.8, and M-91 are conformation-dependent and suggestion that these specific mutations might affect the structure of the protein at least locally. Analysis was performed by site-directed mutagenesis of hILinterface and to the identification of the type of interaction in which they are involved. 6 and hIL-6R and focused on the proposed binding interface between these molecules. Substitutions of amino acids in Structure-based amino acid sequence alignments of hIL-6 with hCNTF 24 and hGH 25 and of their corresponding first hIL-6 and hIL-6R, which were predicted by our model to interact with each other, showed the expected results. The binding receptors, 25, 26 respectively, show that the sequence homology between the corresponding proteins is low (Fig structural integrity of these mutants was confirmed by their recognition by at least three different conformation-depen-8). In general, the similarity between the receptors (Fig 8B) is higher than among the cytokines (Fig 8A) . Insertions and dent MoAbs. Thus, we were able to verify the involvement of amino acid residues suspected of being directly involved deletions occurred probably in the loop regions, because their alignment is more difficult. Nevertheless, the general in the binding between hIL-6 and hIL-6R and to identify additional ones. Our results allow the identification of the location of certain major binding sites is conserved in the protein structures and is similar to those used in hIL-6 and different zones of interaction between the two proteins. They show that recognition epitopes for hIL-6R are located mainly hIL-6R, respectively (Fig 8) . The sequence differences observed in these sites reflect the specificity. Equivalents for in the beginning of the A-helix and in the ends of the AB loop and D-helix of hIL-6 (Fig 8A) . Recognition epitopes some of the interaction regions in the hGH/hGHR were not found in the hIL-6/hIL-6R complex and probably will not for hIL-6 are located mainly in loops EF of domain-I and BC and FG of domain II of hIL-6R (Fig 8B) . By changing be located in the CNTF/CNTFR complex (Fig 8) . This is not unexpected, because GH is believed to interact with two the type, size, or charge of the residue in question, we showed that interaction zones in the hIL-6/hIL-6R binding identical receptor subunits, 25 whereas IL-6 and CNTF are thought to interact with at least three different and distinct interface are made up of relatively large aromatic, hydrophobic, or hydrophilic amino acids that are exposed on the surones.
12
A recent report suggested that the binding interface beface of the interacting proteins. This approach has led to the localization of different residue clusters in the binding tween hGH and its receptor resembles a cross-section Interestingly, IL-6R is often secreted in a soluble form (sIL-6R) that binds IL-6 and is biologically active as an formed upon the binding between hGH and hGHR (hGHbp-I), is a hydrophobic region that accounts for most of the agonist, rendering cells expressing gp130, but not IL-6R, responsive to IL-6. This form of the IL-6R shows structural binding-free energy. This hydrophobic core that is dominated by two aromatic tryptophan residues, located in the and functional similarities to the P40 subunit of IL-12. In the functional IL-12 cytokine the P40 subunit is covalently EF and BC loops of the receptor, is surrounded by hydrophilic and partially hydrated residues that seem to contribute linked to a second polypeptide, P35, which is structurally related to IL-6. 57 The IL-12 signal is transduced via a memless to the binding affinity. 53 The architecture of the IL-6/ IL-6R contact region is similar to the one described above.
brane bound receptor resembling gp130. 58 Taken together, the findings discussed above suggest that the IL-6/sIL-6R Aromatic residues from the EF and BC loops of the receptor are at the center of the binding interface. Predominance complex may be considered as a new protein that represents a functionally activated form of the cytokine with a larger of aromatic amino acids can be observed in the EF and BC loops of most of the members of the cytokine receptor target cell population. This may be applicable also to the complexes of CNTF and IL-11 and their corresponding afamily. 10 The involvement of some of these residues in the binding of the ligand by receptors other than hGHR, hPRLR, subunit receptors.
59-61
In view of the current lack of x-ray or NMR structural and hIL-6R (Fig 8B) was shown by mutagenesis. 54-56 It seems highly probable that aromatic residues such as Phe, Trp, and information on IL-6 and its receptor, the three-dimensional model of their complex, validated by mutagenesis, could be Tyr are favored in the functional core, because their side chains provide conformational rigidity and functional plasuseful. Indeed, the existence of disease-related variants of hGH and hGHR was discovered recently. The availability ticity needed for the fitting into critical regions in the binding interface. They probably contribute more to the binding enof structural information on those molecules was of great value in understanding the implications and the mechanism ergy and less to the specificity. The nature of the interactions in which they are involved is dependent on their environof malfunction. [62] [63] [64] Variants carrying mutations in the extracellular domain of hGM-CSFR and c-Mpl were also rement. Affinity is dependent on the actual number of contacts formed between the two binding proteins and on their nature.
ported. 65, 66 Although no such variants of IL-6 nor of IL-6R have been reported so far, it is possible that some will be Large hydrophobic interaction zones may stabilize the complex, whereas specificity is achieved by formation of salt discovered in the near future. The model can also be used for the rational design of bridges around these central binding regions.
For personal use only. on April 15, 2017 . by guest www.bloodjournal.org From Fig 8 (cont'd) J.P.J. Brakenhoff for their anti-hIL-6R and anti-hIL-6 MoAbs, antagonistic variants of IL-6 and sIL-6R. 18, 67 The topology which were used in this study.
of the binding site corresponding to Tyr188, Phe248, and Tyr249 of IL-6R and Phe74 and Phe78 of hIL-6 can be used
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